Cargando…
Editorial: Novel antipsychotics within and beyond clinical trials: The treatment of overlapping psychiatric disorders with D3-D2 partial agonists
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555016/ https://www.ncbi.nlm.nih.gov/pubmed/36245871 http://dx.doi.org/10.3389/fpsyt.2022.1038627 |
| _version_ | 1784806821969526784 |
|---|---|
| author | Németh, György Csehi, Réka |
| author_facet | Németh, György Csehi, Réka |
| author_sort | Németh, György |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9555016 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95550162022-10-13 Editorial: Novel antipsychotics within and beyond clinical trials: The treatment of overlapping psychiatric disorders with D3-D2 partial agonists Németh, György Csehi, Réka Front Psychiatry Psychiatry Frontiers Media S.A. 2022-09-28 /pmc/articles/PMC9555016/ /pubmed/36245871 http://dx.doi.org/10.3389/fpsyt.2022.1038627 Text en Copyright © 2022 Németh and Csehi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Psychiatry Németh, György Csehi, Réka Editorial: Novel antipsychotics within and beyond clinical trials: The treatment of overlapping psychiatric disorders with D3-D2 partial agonists |
| title | Editorial: Novel antipsychotics within and beyond clinical trials: The treatment of overlapping psychiatric disorders with D3-D2 partial agonists |
| title_full | Editorial: Novel antipsychotics within and beyond clinical trials: The treatment of overlapping psychiatric disorders with D3-D2 partial agonists |
| title_fullStr | Editorial: Novel antipsychotics within and beyond clinical trials: The treatment of overlapping psychiatric disorders with D3-D2 partial agonists |
| title_full_unstemmed | Editorial: Novel antipsychotics within and beyond clinical trials: The treatment of overlapping psychiatric disorders with D3-D2 partial agonists |
| title_short | Editorial: Novel antipsychotics within and beyond clinical trials: The treatment of overlapping psychiatric disorders with D3-D2 partial agonists |
| title_sort | editorial: novel antipsychotics within and beyond clinical trials: the treatment of overlapping psychiatric disorders with d3-d2 partial agonists |
| topic | Psychiatry |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555016/ https://www.ncbi.nlm.nih.gov/pubmed/36245871 http://dx.doi.org/10.3389/fpsyt.2022.1038627 |
| work_keys_str_mv | AT nemethgyorgy editorialnovelantipsychoticswithinandbeyondclinicaltrialsthetreatmentofoverlappingpsychiatricdisorderswithd3d2partialagonists AT csehireka editorialnovelantipsychoticswithinandbeyondclinicaltrialsthetreatmentofoverlappingpsychiatricdisorderswithd3d2partialagonists |